New treatment of periodontal diseases by using NF-κB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing

Antioxidants and Redox Signaling

Volumn 11, Issue 9, 2009, Pages 2065-2075

  Shimizu, Hideo ^a   Nakagami, Hironori ^a   Morita, Shosuke ^b   Tsukamoto, Ikuyo ^c   Osako, Mariana Kiomy ^a   Nakagami, Futoshi ^a   Shimosato, Takashi ^d   Minobe, Noriko ^d   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA DENTAL UNIVERSITY   (Japan)

^c NARA WOMEN'S UNIVERSITY   (Japan)

^d Nissei Bilis Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE METABOLISM; CONTROLLED STUDY; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; EXPERIMENTAL DOG; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; TOOTH RADIOGRAPHY; WOUND HEALING;

ABSORPTIOMETRY, PHOTON; ANIMALS; BASE SEQUENCE; BONE RESORPTION; CELLS, CULTURED; DNA PRIMERS; DOGS; HUMANS; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PERIODONTAL DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WOUND HEALING;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS;

EID: 68949211360     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2355     Document Type: Article

References (31)

1. Akira S and Takeda K. Toll-like receptor signaling. Nat Rev Immunol 4: 499-511, 2004.
2. Cochran DI. Inflammation and bone loss in periodontal diseases. J Periodontol 79: 1569-1576, 2008.
3. Farman M and Joshi RI. Full-mouth treatment versus quadrant root surface debridement in the treatment of chronic periodontitis: a systematic review. Br Dent J 205:E18;discussion 496-497, 2008.
4. Fujihashi K, Yamamoto M, Hiroi T, Bamberg TV, McGhee JR, and Kiyono H. Selected Th1 and Th2 cytokine mRNA expression by CD4(+)T cells isolated from inflamed human gingival tissues. Clin Exp Immunol 10: 422-428, 1996.
5. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, and Silva JS. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL and their physiological inhibitors. Oral/Microbiol Immunol 21: 12-20, 2006.
6. Han X, Kawai T, Eastcott JW, and Taubman MA. Bacteria-responsive B lymphocytes induce periodontal bone resorption. J Immunol 176: 625-631, 2006.
7. Holmstrup P, Poulsen AH, Andersen L, Skuldbøl T, and Fiehn NE. Oral infections and systemic diseases. Dent Clin North Am 47: 575-598, 2003.
8. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, Goncalves RB, Valverde P, Dibart S, Li YP, Miranda LA, Ernst CWO, Izumi Y, and Taubman MA. B and T lymphocytes are the primary source of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 169: 987-998, 2006.
9. Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, and Yoshikai Y. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 166: 3574-3579, 2001.
10. Lohinai Z, Benedek P, Fehér E, Györfi A, Rosivall L, Fazekas A, Salzman AL, and Szabó C. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase in ligature-induced periodontitis in the rat. Br J Pharmacol 83: 353-360, 2004.
11. Martuscelli G, Fiorellini JP, Crohin CC, and Howell TH. The effect of interleukin 11 on the ligature-induced periodontal disease in the beagle dog. J Periodontol 71: 573-578, 2000.
12. Mogi M, Otogoto J, Ota N, and Togari A.Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 83: 166-169, 2004.
13. Murakami S, Takayama S, Ikezawa K, Shimabukuro Y, Kitamura M, Nozaki T, Terashima A, Asano T, and Okada H. Regeneration of periodontal tissues by basic fibrablast growth factors. J Periodont Res 34: 425-430, 1999.
14. Nair SP, Meghji S, Wilson M, Reddi K, White P, and Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 64: 2371-2380, 1996.
15. Ogawa T and Uchida H. A peptide, ALTTE, within the fimbrial subunit protein from Porphyromonas gingivalis, induces production of interleukin 6 gene expression and protein phosphorylation in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 11: 197-206, 1995.
16. Page RC and Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 14: 9-11, 1997.
17. Rodrigues DC, Taba MJ, Novaes AB, Souza SL, and Grisi MF. Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 74: 1361-1367, 2003.
18. Sacco G, Carmagnola D, Abati S, Luglio PF, Ottolenghi L, Villa A, Maida C, and Campus G. Periodontal disease and preterm birth relationship. Minerva Stomatol 57: 233-246, 2008.
19. Sakallioǧlu U, Açikgöz G, Ayas B, Kirtiloǧlu T, and Sakallioǧlu E. Healing of periodontal defects treated with enamel matrix proteins and root surface conditioning: an experimental study in dogs. Biomaterials 25: 1831-1840, 2004.
20. Shimizu H, Nakagami H, Tsukamoto I, Morita S, Kunugiza Y, Tomita T, Yoshikawa H, Kaneda Y, Ogihara T, and Morishita R. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts. Gene Ther 13: 933-941, 2006.
21. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, and Morishita R. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22: 2465-2475, 2008.
22. Socransky SS, Haffajee AD, Goodson JM, and Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol 11: 21-32, 1984.
23. Sone T, Tamada T, Jo Y, Miyoshi H, and Fukunaga M. Analysis of three-dimensional microarchitecture and degree of mineralization in bone metastases from prostate cancer using synchrotron microcomputed tomography. Bone 35: 432-438, 2004.
24. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, and Taniguchi T. T cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408: 600-605, 2000.
25. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, Ellen RP, and Penninger JM. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 106: R59-R67, 2000.
26. Tomita T, Takano H, Tomita N, Morishita R, Kaneko M, Shi K, Takahi K, Nakase T, Kaneda Y, Yoshikawa H, and Ochi T. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. Rheumatology (Oxford) 39: 749-757, 2000.
27. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, and Deanfield J. Treatment of periodontitis and endothelial function. N Engl J Med. 356: 911-920, 2007.
28. Venken K, Boonen S, Van Herck E, Vandenput L, Kumar N, Sitruk-Ware R, Sundaram K, Bouillon R, and Vanderschueren D. Bone and muscle protective potential of the prostatesparing synthetic androgen 7α-methyl-19- nortestosterone: evidence from the aged orchidectomized male rat model. Bone 36: 663-670, 2005.
29. Wara AN, Surarit R, Chayasadom A, Boch JA, and Pitiphat W. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis. J Periodontol 78: 1062-1069, 2007.
30. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, and Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95: 3597-3602, 1998.
31. Zhang D, Chen L, Li S, Gu Z, and Yan J. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1 beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun 14: 99-107, 2008.